(Q34027944)

30 July 2017

0 references

1 reference

title

Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review (English)

1 reference

30 July 2017

1 reference

Rajender Agarwal

1

1 reference

30 July 2017

David N Schwartz

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

Clinical Infectious Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

53

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

379-387

1 reference

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Test result variation and the quality of evidence-based clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR408

21 January 2018

Identifiers

DOI

10.1093/CID/CIR408

1 reference

release_k3fsyzjtijg4pfgtdsozuax5gm

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k3fsyzjtijg4pfgtdsozuax5gm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference